Recap: Biohaven Pharma Hldgs Q1 Earnings

Biohaven Pharma Hldgs BHVN reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.

Biohaven Pharma Hldgs beat estimated earnings by 35.97%, reporting an EPS of $-1.62 versus an estimate of $-2.53.

Revenue was up $275.03 million from the same period last year.

Last quarter the company missed on EPS by $0.28 which was followed by a 8.87% drop in the share price the next day.

Here's a look at Biohaven Pharma Hldgs's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-2.04	-2.40	-2.74	-2.82
EPS Actual	-2.32	-1.91	-2.62	-2.97
Revenue Estimate	173.69M	128.40M	78.13M	40.63M
Revenue Actual	190.01M	135.74M	92.93M	43.82M

To track all earnings releases for Biohaven Pharma Hldgs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar